Key insights
- Intuitive Surgical announced updates to its da Vinci 5 system, including remote capabilities and extended instrument use. Strong adoption metrics and analyst revisions point to continued growth. The positive news may provide a slight boost to ISRG and the broader medical device sector.
SUNNYVALE, Calif. - Intuitive Surgical (NASDAQ:ISRG) announced updates to its da Vinci 5 robotic surgical system and extended use capabilities for its instruments, according to a company press release statement issued today.
The company said more than 100 updates will be available to da Vinci 5 users starting in June in the U.S., with global availability subject to regulatory clearances. The updates include enhancements to Intuitive Telepresence, which allows remote physicians to observe procedures, adding a camera for full operating room visibility and a live cursor feature.
Additional features expected later this year in the U.S., pending regulatory clearance, include a digital ruler for on-screen measurement between 3 and 15 centimeters, surgeon-initiated tool eject capability, and multi-arm targeting for case setup.
Intuitive stated that five of six available Force Feedback instruments have had their number of uses increased from six to 15, with one instrument cleared for 10 uses. The company said it anticipates increasing the number of uses on certain core instruments in 2027.
The company reported that more than 1,400 da Vinci 5 systems have been installed globally, with more than 380,000 procedures performed by more than 12,800 surgeons in 10 countries as of the first quarter of 2026.The strong adoption metrics align with Intuitive’s robust financial performance. The company, valued at $159 billion, posted 21% revenue growth in the last twelve months with gross profit margins of 66%. According to InvestingPro analysis, which identifies the stock as a prominent player in the Healthcare Equipment & Supplies industry, 15 analysts have recently revised earnings upward. For deeper insights, investors can access a comprehensive Pro Research Report covering ISRG alongside 1,400+ other US equities.
Intuitive said its dV5 Complete Care plan guarantees 98% uptime and is currently exceeding 99% actual uptime. The company also stated it is enhancing instrument encryption technology to improve product security and monitoring.
Six new simulation exercises have been added to SimNow 2, the company’s surgical simulation platform, along with new playlists for targeted learning.
Intuitive is headquartered in Sunnyvale, California, and manufactures the da Vinci surgical system and Ion endoluminal system for minimally invasive procedures.
In other recent news, Intuitive Surgical reported impressive quarterly earnings, exceeding analyst expectations. The company achieved a 23% year-over-year increase in sales, reaching $2.77 billion, and a 38% increase in earnings per share, which stood at $2.50. Gross and operating margins also surpassed estimates, with gross margin at 67.8% and operating margin at 38.9%. Following these results, RBC Capital and Bernstein SocGen Group reiterated their Outperform ratings, with price targets set at $650 and $750, respectively. Meanwhile, Barclays lowered its price target to $651, and Piper Sandler adjusted its target to $580, though both firms maintained an Overweight rating.
In related news, ServiceNow and IBM also released their earnings. ServiceNow slightly exceeded Wall Street estimates but noted challenges due to geopolitical tensions, leading to a significant drop in its share price. IBM surpassed earnings and revenue expectations but chose to keep its guidance unchanged. These developments highlight the dynamic nature of the current financial landscape for software companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.